Retatrutide: What New Trial Results Mean for Weight Loss and Diabetes
Eli Lilly has released the full results of a large, late-stage study of retatrutide, an experimental weekly injection for weight loss. The findings were presented at a major European diabetes conference in Milan and published in The Lancet. They build on early headline numbers the company shared in July. What is retatrutide? Most people know
